These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 12679611)

  • 1. The reduced release of GH by GHRH in 8 subjects aged 65-69 years is augmented considerably by rivastigmine, a drug for Alzheimer's disease.
    Obermayr RP; Mayerhofer L; Knechtelsdorfer M; Tragl KH; Geyer G
    Gerontology; 2003; 49(3):191-5. PubMed ID: 12679611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The age-related down-regulation of the growth hormone/insulin-like growth factor-1 axis in the elderly male is reversed considerably by donepezil, a drug for Alzheimer's disease.
    Obermayr RP; Mayerhofer L; Knechtelsdorfer M; Mersich N; Huber ER; Geyer G; Tragl KH
    Exp Gerontol; 2005 Mar; 40(3):157-63. PubMed ID: 15763392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholinergic modulation of growth hormone responses to growth hormone-releasing hormone in uraemic patients on peritoneal dialysis.
    Díez JJ; Iglesias P; Selgas R; Bajo MA; Aguilera A
    Clin Endocrinol (Oxf); 2000 Nov; 53(5):587-93. PubMed ID: 11106919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of growth hormone-releasing hormone and somatostatin to decreased growth hormone secretion in elderly men.
    Soule SG; Macfarlane P; Levitt NS; Millar RP
    S Afr Med J; 2001 Mar; 91(3):254-60. PubMed ID: 11291426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acipimox-mediated plasma free fatty acid depression per se stimulates growth hormone (GH) secretion in normal subjects and potentiates the response to other GH-releasing stimuli.
    Peino R; Cordido F; Peñalva A; Alvarez CV; Dieguez C; Casanueva FF
    J Clin Endocrinol Metab; 1996 Mar; 81(3):909-13. PubMed ID: 8772549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The decrease in growth hormone (GH) response after repeated stimulation with GH-releasing hormone is partly caused by an elevation of somatostatin tonus.
    Reichardt B; Schrader M; Mojto J; Mehltretter G; Müller OA; Schopohl J
    J Clin Endocrinol Metab; 1996 May; 81(5):1994-8. PubMed ID: 8626871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired growth hormone secretion in obese subjects is partially reversed by acipimox-mediated plasma free fatty acid depression.
    Cordido F; Peino R; Peñalva A; Alvarez CV; Casanueva FF; Dieguez C
    J Clin Endocrinol Metab; 1996 Mar; 81(3):914-8. PubMed ID: 8772550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eptastigmine augments basal and GHRH-stimulated growth hormone release in young and old dogs.
    Cella SG; Imbimbo BP; Pieretti F; Müller EE
    Life Sci; 1993; 53(5):389-95. PubMed ID: 8336517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyridostigmine blocks the inhibitory effect of glucocorticoids on growth hormone-releasing hormone stimulated growth hormone secretion in normal man.
    Giustina A; Girelli A; Doga M; Bodini C; Bossoni S; Romanelli G; Wehrenberg WB
    J Clin Endocrinol Metab; 1990 Sep; 71(3):580-4. PubMed ID: 2118535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous growth hormone (GH)-releasing hormone is required for GH responses to pharmacological stimuli.
    Jaffe CA; DeMott-Friberg R; Barkan AL
    J Clin Invest; 1996 Feb; 97(4):934-40. PubMed ID: 8613546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cholinergic muscarinic blockade on growth hormone responses to growth hormone-releasing hormone in uraemic patients.
    Díez JJ; Iglesias P; Aguilera A; Bajo MA; Selgas R
    Nephrol Dial Transplant; 1999 Jul; 14(7):1704-9. PubMed ID: 10435880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of sex and age on pyridostigmine potentiation of growth hormone-releasing hormone-induced growth hormone release.
    Corsello SM; Tofani A; Della Casa S; Rota CA; Sciuto R; Colasanti S; Barini A; Barbarino A
    Neuroendocrinology; 1992 Aug; 56(2):208-13. PubMed ID: 1407375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous 24-hour intravenous infusion of recombinant human growth hormone (GH)-releasing hormone-(1-44)-amide augments pulsatile, entropic, and daily rhythmic GH secretion in postmenopausal women equally in the estrogen-withdrawn and estrogen-supplemented states.
    Evans WS; Anderson SM; Hull LT; Azimi PP; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2001 Feb; 86(2):700-12. PubMed ID: 11158034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired inhibitory effects of somatostatin on growth hormone (GH)-releasing hormone stimulation of GH secretion after short term infusion.
    Kelijman M; Frohman LA
    J Clin Endocrinol Metab; 1990 Jul; 71(1):157-63. PubMed ID: 1973420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of acute pharmacological reduction of plasma free fatty acids on growth hormone (GH) releasing hormone-induced GH secretion in obese adults with and without hypopituitarism.
    Cordido F; Fernandez T; Martinez T; Peñalva A; Peinó R; Casanueva FF; Dieguez C
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4350-4. PubMed ID: 9851776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyridostigmine potentiates growth hormone (GH)-releasing hormone-induced GH release in both men and women.
    Arvat E; Cappa M; Casanueva FF; Dieguez C; Ghigo E; Nicolosi M; Valcavi R; Zini M
    J Clin Endocrinol Metab; 1993 Feb; 76(2):374-7. PubMed ID: 8432781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of propranolol on GH responsiveness to repeated GH-releasing hormone stimulations in normal subjects.
    Arosio M; Losa M; Bazzoni N; Bochicchio D; Palmieri E; Nava C; Faglia G
    Acta Endocrinol (Copenh); 1990 Jun; 122(6):735-9. PubMed ID: 2115711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GH responsiveness to repeated GHRH or hexarelin administration in normal adults.
    Sartorio A; Conti A; Ferrero S; Spada A; Faglia G
    J Endocrinol Invest; 1995 Oct; 18(9):718-22. PubMed ID: 8719303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of arginine and pyridostigmine on the GHRH-induced GH rise in obesity and Cushing's syndrome.
    Procopio M; Invitti C; Maccario M; Grottoli S; Cavagnini F; Camanni F; Ghigo E
    Int J Obes Relat Metab Disord; 1995 Feb; 19(2):108-12. PubMed ID: 7735336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abuse of recombinant human growth hormone: studies in two different dog models.
    Rigamonti AE; Scanniffio D; Bonomo SM; Cella SG; Sartorio A; Müller EE
    Neuroendocrinology; 2004; 79(5):237-46. PubMed ID: 15218318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.